Mr Mark Chatfield
Mr

Mark Chatfield

Email: 
Phone: 
+61 7 334 65042

Background

A/Prof Mark D. Chatfield is a highly experienced statistician in the UQ Clinical Trials Centre and collaborates with researchers across the Faculty of Health, Medicine and Behavioural Sciences.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 30 NHMRC/MRFF funded (>$57M) studies (mostly clinical trials). He has >20 years of experience as a biostatistician in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009). He has co-supervised 7 PhD students to completion, and is currently an advisor to 2 PhD students.

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc command.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Availability

Mr Mark Chatfield is:
Not available for supervision

Fields of research

Biomedical and Clinical Sciences Biostatistics Health Sciences Mathematical Sciences Statistics

Qualifications

  • Bachelor of Arts, University of Oxford
  • Masters (Coursework), University of Southampton
  • Masters (Coursework), University of Oxford

Research interests

  • Clinical trials

    Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations.

  • Meta-analysis

    Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of ratios. That said, he advocates for the reporting of tau, or exp(tau) for ratios, rather than tau^2 as it is most easily understood.

Search Professor Mark Chatfield’s works on UQ eSpace

300 works between 2004 and 2026
All (300) Journal Article (219) Conference Publication (80) Book Chapter (1)

41 - 60 of 300 works

2024

Conference Publication

Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.

Burgess, A., Chatfield, M., Jackman, M., Thorley, M., Reedman, S., Patel, M., Boyd, R.N. and Sakzewski, L. (2024). Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.. European Academy of Childhood Disabilty, Bruges, Belgium, 29 May-1 June 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.

2024

Journal Article

Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study

Collaro, Andrew J., Foong, Rachel, Chang, Anne B., Marchant, Julie M., Blake, Tamara L., Cole, Johanna F., Pearson, Glenn, Hii, Rebecca, Brown, Henry, Chatfield, Mark D., Hall, Graham and McElrea, Margaret S. (2024). Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study. Medical Journal of Australia, 220 (10), 523-529. doi: 10.5694/mja2.52306

Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study

2024

Journal Article

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

Chang, Anne B., Yerkovich, Stephanie T., Baines, Katherine J., Burr, Lucy, Champion, Anita, Chatfield, Mark D., Eg, Kah P, Goyal, Vikas, Marsh, Robyn L, McCallum, Gabrielle B, McElrea, Margaret, McPhail, Steven, Morgan, Lucy C, Morris, Peter S, Nathan, Anne M, O’Farrell, Hannah, Sanchez, Marion O, Parsons, Marianne, Schultz, André, Torzillo, Paul J, West, Nicholas P, Versteegh, Lesley, Marchant, Julie M and Grimwood, Keith (2024). Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open Respiratory Research, 11 (1) e002216, e002216. doi: 10.1136/bmjresp-2023-002216

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

2024

Journal Article

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Graves, Bianca, Sinclair, Holly, Brischetto, Anna, Lim, Karen, Parkes-Smith, Jill, Eustace, Matthew, Davidson, Natalie, Tabah, Alexis, Stewart, Adam, Chatfield, Mark D., Harris, Patrick N.A. and Paterson, David L. (2024). Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications. Clinical Infectious Diseases, 78 (2), 283-291. doi: 10.1093/cid/ciad663

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

2024

Journal Article

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial

Hardy, Melissa, Harris, Patrick N. A., Paterson, David L., Chatfield, Mark D., Mo, Yin, for the MERINO trial investigators, Tambyah, Paul A., Lye, David C., Lee, Tau H., Yilmaz, Mesut, Alenazi, Thamer H., Arabi, Yaseen, Falcone, Marco, Bassetti, Matteo, Righi, Elda, Rogers, Benjamin A., Kanj, Souha, Bhally, Hasan, Iredell, Jon, Mendelson, Marc, Boyles, Tom H., Looke, David, Miyakis, Spiros, Walls, Genevieve, Al Khamis, Mohammed, Zikri, Ahmed, Crowe, Amy, Ingram, Paul, Daneman, Nick ... Peleg, Anton Y. (2024). Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial. Clinical Infectious Diseases, 78 (6), 1482-1489. doi: 10.1093/cid/ciae050

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial

2024

Conference Publication

The molecular epidemiology of Burkholderia pseudomallei in North Queensland

Gassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Mayer-Coverdale, Johanna, Norton, Robert and Harris, Patrick N.A. (2024). The molecular epidemiology of Burkholderia pseudomallei in North Queensland. Pathology Update 2024, Adelaide, VIC, Australia, 1 - 3 March 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2023.12.133

The molecular epidemiology of Burkholderia pseudomallei in North Queensland

2024

Conference Publication

Nice log (and log-like) scaled axes

Chatfield, Mark (2024). Nice log (and log-like) scaled axes. 11th Oceania Stata Conference, Virtual, 1 February 2024. https://sugm.net.au/2024.html:

Nice log (and log-like) scaled axes

2023

Journal Article

Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study

Peri, Anna Maria, Rafiei, Nastaran, O’Callaghan, Kevin, Brischetto, Anna, Graves, Bianca, Sinclair, Holly, Eustace, Matthew, Lim, Karen, Parkes-Smith, Jill, Stewart, Adam, Davidson, Natalie, Tabah, Alexis, Bergh, Haakon, Chatfield, Mark D., Harris, Patrick N. A. and Paterson, David L. (2023). Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study. Infectious Diseases, 56 (4), 268-276. doi: 10.1080/23744235.2023.2294122

Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study

2023

Journal Article

A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease

King, Shannon J., Reid, Natasha, Brown, Sarah J., Brodie, Lucinda J., Sia, Aaron D. H., Chatfield, Mark D., Francis, Ross S., Peel, Nancye M., Gordon, Emily H. and Hubbard, Ruth E. (2023). A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease. BMC Geriatrics, 23 (1) 664, 664. doi: 10.1186/s12877-023-04365-4

A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease

2023

Journal Article

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

2023

Journal Article

Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants

Patel, Nikita, Dahl, Katrina, O'Rourke, Rachael, Williamson, Anne, Chatfield, Mark D., Fong, Kwun M., Yang, Ian A. and Marshall, Henry M. (2023). Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants. The British Journal of Radiology, 96 (1151) 20220992, 1-9. doi: 10.1259/bjr.20220992

Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants

2023

Journal Article

Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines

Leach, A. J., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, E. K., Santosham, M., Torzillo, P. J., McIntyre, P., Smith-Vaughan, H., Skull, S. A., Oguoma, V. M., Chatfield, M., Lehmann, D., Binks, M. J., Licciardi, P. V., Andrews, R., Snelling, T., Krause, V., Carapetis, J., Chang, A. B. and Morris, P. S. (2023). Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines. International Journal of Pediatric Otorhinolaryngology, 175 111776, 111776. doi: 10.1016/j.ijporl.2023.111776

Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines

2023

Journal Article

Melioidosis Queensland: an analysis of clinical outcomes and genomic factors

Gassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Norton, Robert and Harris, Patrick N. A. (2023). Melioidosis Queensland: an analysis of clinical outcomes and genomic factors. PLoS Neglected Tropical Diseases, 17 (10) e0011697, 1-13. doi: 10.1371/journal.pntd.0011697

Melioidosis Queensland: an analysis of clinical outcomes and genomic factors

2023

Journal Article

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

Peri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

2023

Journal Article

Effect of active motor learning interventions on gross motor function and mobility in children aged 2 to 6 years with bilateral cerebral palsy: a systematic review and meta-analysis

McLeod, Kate L., Thorley, Megan, Reedman, Sarah E., Chatfield, Mark D. and Sakzewski, Leanne (2023). Effect of active motor learning interventions on gross motor function and mobility in children aged 2 to 6 years with bilateral cerebral palsy: a systematic review and meta-analysis. Pediatric Physical Therapy, 35 (4), 412-428. doi: 10.1097/pep.0000000000001041

Effect of active motor learning interventions on gross motor function and mobility in children aged 2 to 6 years with bilateral cerebral palsy: a systematic review and meta-analysis

2023

Journal Article

Monitoring for micronutrient deficiency after bariatric surgery—what is the risk?

Lewis, Carrie-Anne, Osland, Emma J., de Jersey, Susan, Hopkins, George, Seymour, Matthew, Webb, Lindsey, Chatfield, Mark D. and Hickman, Ingrid J. (2023). Monitoring for micronutrient deficiency after bariatric surgery—what is the risk?. European Journal of Clinical Nutrition, 77 (11), 1-13. doi: 10.1038/s41430-023-01318-3

Monitoring for micronutrient deficiency after bariatric surgery—what is the risk?

2023

Journal Article

Diagnostic accuracy of the Hammersmith Neonatal Neurological Examination in predicting motor outcome at 12 months for infants born very preterm

Howard, Grace T., Baque, Emmah, Colditz, Paul B., Chatfield, Mark D., Ware, Robert S., Boyd, Roslyn N. and George, Joanne M. (2023). Diagnostic accuracy of the Hammersmith Neonatal Neurological Examination in predicting motor outcome at 12 months for infants born very preterm. Developmental Medicine and Child Neurology, 65 (8), 1061-1072. doi: 10.1111/dmcn.15512

Diagnostic accuracy of the Hammersmith Neonatal Neurological Examination in predicting motor outcome at 12 months for infants born very preterm

2023

Journal Article

Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis

Legg, Amy, Roberts, Matthew A., Davies, Jane, Cass, Alan, Meagher, Niamh, Sud, Archana, Daitch, Vered, Dishon-Benattar, Yael, Yahav, Dafna, Paul, Mical, Xinxin, Chen, He Ping, Yeo, Lye, David, Lee, Russel, Robinson, J Owen, Foo, Hong, Tramontana, Adrian R., Bak, Narin, Grenfell, Adelaide, Rogers, Benjamin, Li, Ying, Joshi, Neela, O’Sullivan, Matthew, McKew, Genevieve, Ghosh, Niladri, Schneider, Kellie, Holmes, Natasha E., Dotel, Ravindra, Chia, Timothy ... Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Study Group (2023). Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis. Open Forum Infectious Diseases, 10 (7) ofad337, 1. doi: 10.1093/ofid/ofad337

Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis

2023

Journal Article

A single-blind, parallel-group randomised trial of a technology-assisted and remotely delivered cognitive behavioural therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trial

Dissanayaka, Nadeeka, Brooks, Deborah, Worthy, Peter, Mitchell, Leander, Pachana, Nancy A., Byrne, Gerard, Keramat, Syed Afroz, Comans, Tracy, Bennett, Sally, Liddle, Jacki, Chatfield, Mark D., Broome, Annette, Oram, Joanne, Appadurai, Kanaganayagam, Beattie, Elizabeth, Au, Tiffany, King, Teagan, Welsh, Kimberley and Pietsch, Ann (2023). A single-blind, parallel-group randomised trial of a technology-assisted and remotely delivered cognitive behavioural therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trial. Trials, 24 (1) 420, 1-17. doi: 10.1186/s13063-023-07381-2

A single-blind, parallel-group randomised trial of a technology-assisted and remotely delivered cognitive behavioural therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trial

2023

Conference Publication

New technology assisted interventions to combat anxiety and depression in dementia

Dissanayaka, N.N., Pacas Fronza, G., Mitchell, L., Pachana, N., Worthy, P., Byrne, G., Keramat, S.A., Comans, T., Bennett, S., Liddle, J., Chatfield, M., Broome, A., Oram, J., Appadurai, K., Beattie, E., Welsh, K., King, T., Brimelow, R., Burley, C., Pietsch, A., Brooks, D. and Au, T. (2023). New technology assisted interventions to combat anxiety and depression in dementia. Australian Dementia Research Forum 2023, Gold Coast, QLD Australia, 29-31 May 2023.

New technology assisted interventions to combat anxiety and depression in dementia

Current funding

  • 2026 - 2028
    Matching multidisciplinary management strategies to people with chronic musculoskeletal pain: the MATCH pilot and feasibility randomised clinical trial
    NHMRC MRFF Novel treatments and management strategies for chronic pain
    Open grant
  • 2026 - 2028
    Vibrotexture Insole Technology for Balance Rehabilitation in People with Multiple Sclerosis
    Multiple Sclerosis Research Australia
    Open grant
  • 2025 - 2028
    Improving Food Allergy Outcomes in Adolescents
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2028
    The clinical and cost effectiveness of the Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors (The FISS-AUSTRALIA trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2024 - 2027
    Losing touch: Exploring the neurophysiological effects of bionic sensory insole technology for balance rehabilitation
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Co-creating virtual environments with consumers to enhance self-awareness and preparedness for home after brain injury
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2028
    The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2023 - 2028
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2027
    Pharmacogenomics for better treatment of fungal infections in cancer
    MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
    Open grant
  • 2022 - 2028
    ACTIVE KNEECAPs! tArgeted effeCTIVE treatments for adolescent KNEECAP pain
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2028
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2019 - 2026
    Preventing recurrent respiratory-related hospitalisations in young Indigenous children through regular azithromycin: a multi-centre.... (NHMRC Project Grant led by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant

Past funding

  • 2019 - 2024
    Improving outcomes of children and young adults with primary ciliary dyskinesia (PCD):... (MRFF RCRDUN administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2019
    Cluster randomised trial of Staphylococcus aureus decolonisation to prevent surgical site infections
    HCF Research Foundation
    Open grant

Availability

Mr Mark Chatfield is:
Not available for supervision

Supervision history

Current supervision

  • Doctor Philosophy

    Novel trial design in evaluation of antibiotics.

    Associate Advisor

    Other advisors: Dr Patrick Harris

Completed supervision

Enquiries

For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au